Aoki J - Search Results

1

11C-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET.

Zhang H, Tian M, Oriuchi N, Higuchi T, Watanabe H, Aoki J, Tanada S, Endo K. Zhang H, et al. Among authors: aoki j. Nucl Med Commun. 2003 Mar;24(3):273-9. doi: 10.1097/00006231-200303000-00007. Nucl Med Commun. 2003. PMID: 12612468

2

Utility of FDG-PET in differential diagnosis of benign and malignant fractures in acute to subacute phase.

Kato K, Aoki J, Endo K. Kato K, et al. Among authors: aoki j. Ann Nucl Med. 2003 Feb;17(1):41-6. doi: 10.1007/BF02988257. Ann Nucl Med. 2003. PMID: 12691129

3

FDG-PET for evaluating musculoskeletal tumors: a review.

Aoki J, Endo K, Watanabe H, Shinozaki T, Yanagawa T, Ahmed AR, Takagishi K. Aoki J, et al. J Orthop Sci. 2003;8(3):435-41. doi: 10.1007/s10776-001-0539-6. J Orthop Sci. 2003. PMID: 12768492 Review.

4

High [18F] 2-fluoro-2-deoxy-D-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing's syndrome.

Shimizu A, Oriuchi N, Tsushima Y, Higuchi T, Aoki J, Endo K. Shimizu A, et al. Among authors: aoki j. Ann Nucl Med. 2003 Jul;17(5):403-6. doi: 10.1007/BF03006609. Ann Nucl Med. 2003. PMID: 12971640

5

18F alpha-methyl tyrosine PET studies in patients with brain tumors.

Inoue T, Shibasaki T, Oriuchi N, Aoyagi K, Tomiyoshi K, Amano S, Mikuni M, Ida I, Aoki J, Endo K. Inoue T, et al. Among authors: aoki j. J Nucl Med. 1999 Mar;40(3):399-405. J Nucl Med. 1999. PMID: 10086702 Free article. Clinical Trial.

6

FDG-PET in differential diagnosis and grading of chondrosarcomas.

Aoki J, Watanabe H, Shinozaki T, Tokunaga M, Inoue T, Endo K. Aoki J, et al. J Comput Assist Tomogr. 1999 Jul-Aug;23(4):603-8. doi: 10.1097/00004728-199907000-00022. J Comput Assist Tomogr. 1999. PMID: 10433294

7

Accuracy of standardized uptake value measured by simultaneous emission and transmission scanning in PET oncology.

Inoue T, Oriuchi N, Kunio M, Tomiyoshi K, Tomaru Y, Aoyagi K, Amano S, Suzuki H, Aoki J, Sato T, Endo K. Inoue T, et al. Among authors: aoki j. Nucl Med Commun. 1999 Sep;20(9):849-57. doi: 10.1097/00006231-199909000-00012. Nucl Med Commun. 1999. PMID: 10533192 Clinical Trial.

8

Tc-99m (V) dimercaptosuccinic acid scintigraphy for bone and soft tissue lesions.

Shinozaki T, Hirano T, Watanabe H, Aoki J, Takagishi K. Shinozaki T, et al. Among authors: aoki j. Clin Nucl Med. 2000 Aug;25(8):637-40. doi: 10.1097/00003072-200008000-00021. Clin Nucl Med. 2000. PMID: 10944029 No abstract available.

9

Glucose metabolic analysis of musculoskeletal tumours using 18fluorine-FDG PET as an aid to preoperative planning.

Watanabe H, Shinozaki T, Yanagawa T, Aoki J, Tokunaga M, Inoue T, Endo K, Mohara S, Sano K, Takagishi K. Watanabe H, et al. Among authors: aoki j. J Bone Joint Surg Br. 2000 Jul;82(5):760-7. doi: 10.1302/0301-620x.82b5.9824. J Bone Joint Surg Br. 2000. PMID: 10963181

10

Preliminary study of proton magnetic resonance spectroscopy in bone and soft tissue tumors: an unassigned signal at 2.0-2.1 ppm may be a possible indicator of malignant neuroectodermal tumor.

Oya N, Aoki J, Shinozaki T, Watanabe H, Takagishi K, Endo K. Oya N, et al. Among authors: aoki j. Radiat Med. 2000 May-Jun;18(3):193-8. Radiat Med. 2000. PMID: 10972550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,164 results

Search Page

Filters